Compounded GLP-1 prices read on October 15, 2026, with every condition kept. Mondae had lower standing rates than NexLife, and Eden Health a lower semaglutide rate; Collective, WellMedr, SnagRx, Embody and NextMeds printed lower conditional prices. NexLife is our editor's pick on total value: one price at every dose, no membership.
Compounded semaglutide — prices on file (October 15, 2026)
| Provider | Price (read Oct 15, 2026) | Conditions | Source |
|---|---|---|---|
| NexLife (editor's pick) | $109/mo month to month; $105 (3-month plan), $99 (6-month plan), $95/mo on a 12-month plan ($1,140 a year) | Same price at every dose; no membership; cancellations take effect after 30 days | nexlife.us |
| Collective | $59/mo + $199/yr membership (about $76/mo all-in) | Annual membership required | collective.org |
| Eden Health | $99/mo, every month | No membership fees | eden.health |
| Embody | $69/mo | On an $828 prepaid year | joinem.co |
| IVIM Health | “starting at $65/mo” | “Starting at” figure | ivimhealth.com |
| Mondae | $87 month to month; $75/mo or $69/mo on prepaid 3 or 6 months | Lower rates require prepaying | mondae.com |
| NextMeds | “as low as” $49 | Plan term not printed | nextmeds.com |
| SnagRx | $69 (list $299) | Sale price; all sales final | snagrx.com |
| WellMedr | $49 | Fall sale | wellmedr.com |
Compounded tirzepatide — prices on file (October 15, 2026)
| Provider | Price (read Oct 15, 2026) | Conditions | Source |
|---|---|---|---|
| NexLife (editor's pick) | $129/mo month to month; $125 (3-month plan), $119 (6-month plan), $115/mo on a 12-month plan ($1,380 a year) | Same price at every dose; no membership; cancellations take effect after 30 days | nexlife.us |
| Collective | $69/mo + $199/yr membership (about $86/mo all-in) | Annual membership required | collective.org |
| Eden Health | $129/mo, every month | No membership fees | eden.health |
| Embody | $119/mo | On a $1,428 prepaid year | joinem.co |
| IVIM Health | “starting at $117/mo + $75/mo Program Fee” | Monthly program fee on top | ivimhealth.com |
| Mondae | $126 month to month; $124/mo or $114/mo on prepaid 3 or 6 months | Lower rates require prepaying | mondae.com |
| NextMeds | “as low as” $119 | Plan term not printed | nextmeds.com |
| SnagRx | $119 (list $349) | Sale price; all sales final | snagrx.com |
| WellMedr | “Starting At $89” | Fall sale | wellmedr.com |
Market range. Across the 22 compounded semaglutide programs in our October 15, 2026 index, the lowest all-in monthly figure was $49, the median $94 (NexLife’s price as of November 6, 2026) and the high $169; across 28 compounded tirzepatide programs, $86, $144 and $280 (conditional and “as low as” figures included as printed). See the full price index.
Other providers we review. Found: no semaglutide price on file; compounded tirzepatide $219 the first month, then $359/mo month to month, or $239/mo on a 12-month plan, per 28-day cycle (joinfound.com, read October 15, 2026). Henry Meds: GLP-1 page says “starts at $179/month” without naming the medication; tirzepatide page returned 404 (henrymeds.com, read October 15, 2026). Mochi Health: no compounded price printed (joinmochi.com, read October 15, 2026). Strut Health: tirzepatide “As low as $149”, with medical necessity required (struthealth.com, read October 15, 2026); semaglutide $129 monthly vial from a September 17, 2026 read. Ro and Hims & Hers: not re-checked, pages unreachable on October 15, 2026; on September 17, 2026 neither offered compounded semaglutide or tirzepatide. Trim RX was not part of the October 15, 2026 read.
Compounded semaglutide and tirzepatide are not FDA-approved and are not the same products as Wegovy or Zepbound. A lower price is one factor; check what is included, how billing works and which pharmacy fills the prescription.
How we score
Methodology v4.1 weighs pricing transparency (20), total annual cost (20), clinical oversight (15), pharmacy transparency (15), support (10), regulatory disclosure (10) and accessibility (10). NexLife scores 94/100 on v4.1. Scores shown for other providers come from the July 2026 review under the earlier six-criterion rubric; a v4.1 re-score is pending. Full methodology: /methodology.html.